A Receptor-interacting Protein 1 (RIP1)-independent Necrotic Death under the Control of Protein Phosphatase PP2A That Involves the Reorganization of Actin Cytoskeleton and the Action of Cofilin-1

被引:21
|
作者
Tomasella, Andrea [1 ]
Blangy, Anne [2 ]
Brancolini, Claudio [1 ]
机构
[1] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy
[2] Univ Montpellier, CNRS, CRBM, UMR 5237, F-34293 Montpellier 5, France
关键词
CELL-DEATH; PROGRAMMED NECROSIS; POLY(ADP-RIBOSE) POLYMERASE-1; MEMBRANE PERMEABILIZATION; CASPASE ACTIVATION; SIGNALING COMPLEX; APOPTOSIS; UBIQUITIN; KINASE; 2A;
D O I
10.1074/jbc.M114.575134
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell death by necrosis is emerging not merely as a passive phenomenon but as a cell-regulated process. Here, by using different necrotic triggers, we prove the existence of two distinct necrotic pathways. The mitochondrial reactive oxygen species generator 2,3-dimethoxy-1,4-naphthoquinone elicits necrosis characterized by the involvement of RIP1 and Drp1. However, G5, a non-selective isopeptidase inhibitor, triggers a distinct necrotic pathway that depends on the protein phosphatase PP2A and the actin cytoskeleton. PP2A catalytic subunit is stabilized by G5 treatment, and its activity is increased. Furthermore, PP2Ac accumulates into the cytoplasm during necrosis similarly to HMGB1. We have also defined in the actin-binding protein cofilin-1 a link between PP2A, actin cytoskeleton, and necrotic death. Cofilin-1-severing/depolymerization activity is negatively regulated by phosphorylation of serine 3. PP2A contributes to the dephosphorylation of serine 3 elicited by G5. Finally, a cofilin mutant that mimics phosphorylated Ser-3 can partially rescue necrosis in response to G5.
引用
收藏
页码:25699 / 25710
页数:12
相关论文
共 9 条
  • [1] Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury
    Linkermann, Andreas
    Braesen, Jan H.
    Himmerkus, Nina
    Liu, Shuya
    Huber, Tobias B.
    Kunzendorf, Ulrich
    Krautwald, Stefan
    KIDNEY INTERNATIONAL, 2012, 81 (08) : 751 - 761
  • [2] Discovery of a Highly Potent, Selective, and Metabolically Stable Inhibitor of Receptor-Interacting Protein 1 (RIP1) for the Treatment of Systemic Inflammatory Response Syndrome
    Ren, Yan
    Su, Yaning
    Sun, Liming
    He, Sudan
    Meng, Lingjun
    Liao, Daohong
    Liu, Xiao
    Ma, Yongfen
    Liu, Chunyan
    Li, Sisi
    Ruan, Hanying
    Lei, Xiaoguang
    Wang, Xiaodong
    Zhang, Zhiyuan
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (03) : 972 - 986
  • [3] Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities
    Shi, Kunyu
    Zhang, Jifa
    Zhou, Enda
    Wang, Jiaxing
    Wang, Yuxi
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (22) : 14971 - 14999
  • [4] Protease Activity of Procaspase-8 Is Essential for Cell Survival by Inhibiting Both Apoptotic and Nonapoptotic Cell Death Dependent on Receptor-interacting Protein Kinase 1 (RIP1) and RIP3
    Kikuchi, Mina
    Kuroki, Shunsuke
    Kayama, Mitsuhiro
    Sakaguchi, Shota
    Lee, Kyung-Kwon
    Yonehara, Shin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (49) : 41165 - 41173
  • [5] Distinctive roles of receptor-interacting protein kinases 1 and 3 in caspase-independent cell death of L929
    Park, Seung Yeon
    Shim, Jung Hyun
    Cho, Young Sik
    CELL BIOCHEMISTRY AND FUNCTION, 2014, 32 (01) : 62 - 69
  • [6] IκB Kinaseα/β Control Biliary Homeostasis and Hepatocarcinogenesis in Mice by Phosphorylating the Cell-Death Mediator Receptor-Interacting Protein Kinase 1
    Koppe, Christiane
    Verheugd, Patricia
    Gautheron, Jeremie
    Reisinger, Florian
    Kreggenwinkel, Karina
    Roderburg, Christoph
    Quagliata, Luca
    Terracciano, Luigi
    Gassler, Nikolaus
    Tolba, Rene H.
    Boege, Yannick
    Weber, Achim
    Karin, Michael
    Luedde, Mark
    Neumann, Ulf P.
    Weiskirchen, Ralf
    Tacke, Frank
    Vucur, Mihael
    Trautwein, Christian
    Luescher, Bernhard
    Preisinger, Christian
    Heikenwalder, Mathias
    Luedde, Tom
    HEPATOLOGY, 2016, 64 (04) : 1217 - 1231
  • [7] The C-terminal Domain of the Long Form of Cellular FLICE-inhibitory Protein (c-FLIPL) Inhibits the Interaction of the Caspase 8 Prodomain with the Receptor-interacting Protein 1 (RIP1) Death Domain and Regulates Caspase 8-dependent Nuclear Factor κB (NF-κB) Activation
    Matsuda, Iyo
    Matsuo, Kentaro
    Matsushita, Yuka
    Haruna, Yasushi
    Niwa, Masamitsu
    Kataoka, Takao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (07) : 3876 - 3887
  • [8] Scaffold hopping derived novel benzoxazepinone receptor-interacting protein kinase 1 (RIP1) inhibitors as anti-necroptosis agents: Anti-inflammatory effect in systemic inflammatory response syndrome (SIRS) and epilepsy
    Jiang, Ruiqi
    Xu, Bin
    Zhi, Shumeng
    Sun, Lei
    Yu, Baocong
    Huang, Qing
    Shi, Ying
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 269
  • [9] Interaction Patches of Procaspase-1 Caspase Recruitment Domains (CARDs) Are Differently Involved in Procaspase-1 Activation and Receptor-interacting Protein 2 (RIP2)-dependent Nuclear Factor κB Signaling
    Kersse, Kristof
    Lamkanfi, Mohamed
    Bertrand, Mathieu J. M.
    Vanden Berghe, Tom
    Vandenabeele, Peter
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (41) : 35874 - 35882